PhDs from Dana Farber Cancer Institute / Harvard Medical School Call JBNI Genomics' Bioprin, "Remarkable"
JBNI's 100 Percent Herbal Bioprin Formula Demonstrates High Anti-cancer Tumor Efficacy at Dana Farber Cancer Institute / Harvard Medical School Dana Farber Cancer Institute / Harvard Medical School report shows that the anti-tumor efficacy of Bioprin exceeds selected chemotherapeutic agents. The DFCI/HMS report further states that Bioprin's formula is comparable to the effectiveness of radiation therapy. Most surprising is the all-herbal 100% natural formula's (originally intended for relaxation and comfort) TGD score when used in addition to chemo and radio therapies.
Canyon Park, WA (PRWEB) July 31, 2008 -- The following press release is provided to Cancer researchers only and is to be used only as data for scientific research purposes.
JBNI today released a Dana-Farber Cancer Institute / Harvard Medical School (DFCI/HMS) anti-tumor activity report regarding Formula 15.3 (Bioprin) by Dr. Beverly A. Teicher's and her team. The report entitled, "Efficacy of orally administered herb preparations against the EMT-6/Parent Tumor," clinically documents the effect of JBNI's all-herbal formula on the "equivalent to human metastatic breast cancer." The report illustrates the potential of naturally occurring herbs for use in clinical / medical applications.
"Remarkable." - Dr. Beverly A. Teicher's Report.
In the summary by Dr. Marianne Spada, Ph.D., the doctor notes that, "JJ-15.3 shows at the dose of 500mg/kg a TGD of 4.15 plus or minus 0.53, which is much more potent than (common chemotherapeutic agents) Melpahlan (2.3tgd) or Carmustine (2.5tgd), and comparable to radiotherapy or Cysplatin in treatment of metastatic cancer." Dr. Spada goes on to project, "With higher dose and more frequency than current testing (14 days dose), we might observe much greater TGD than current result even with the current level of herbal concentration."
A full test result spread sheet was also just released. It is entitled, "Tumor growth delay of Herbal Mixture JJ-15.3 in the EMT-6 Murine Marrary Carcinoma at 500mm cubed." In it, the total anti-tumor effect when supporting x-ray radiation therapy (1 wk at 300 rads = 4.3tgd) with JBNI's Formula 15.3 is shown to be 5.15tgd plus or minus 0.61.
When asked about the aggressive nature of 15.3's effect on cancer cells and potential safety issues, JBNI Investor Relations Manager, Ken Case quoted Dr. Teicher's report saying, "Formula 15.3 has already CONTINUED ORIGINAL RELEASE: http://www.prweb.com/releases/2008/07/prweb1158214.htm
___
WordPress: http://herbholist.wordpress.com
Tumblr: http://herbholist.tumblr.com
Posterous: http://herbholist.posterous.com
Youtube: http://youtube.com/biodrux
Twitter: http://twitter.com/herbholist
“Holistic Health Myths You Still Believe or Don’t but Still Do:” http://herbholist.com Submit Your Site and Meet Partners. Team Up! http://jbni.us
FCC DISCLOSURE: JBNI is the producer of the content on this website and is the producer of 100% Natural, All-Herbal Formulas for Humanity’s Rapidly Evolving Needs and can be reached at http://jbni.us and 425 408 9091
###
